Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.
Login6 requirements across 5 categories
Sign up to view complete requirements and analysis
3 documents available with AI summaries
This document outlines the tender requirements for the procurement of parenteral oncological drugs for 2027 and 2028, detailing selection criteria, technical and financial proposal requirements, and evaluation methods.
This document contains Appendix 1, which is part of the open tender for the procurement of parenterally administered oncological drugs for 2027 and 2028, organized by the National Health Service.
This document contains the basic data for a tender notice regarding the procurement of parenteral oncological drugs for 2027 and 2028, issued by the National Health Service of Latvia.
Sign up to view document summaries and analysis
This tender for oncological drugs is generally well-structured with clear documentation, but lacks transparency regarding financial value and specific evaluation criteria. The process is largely compliant with e-procurement standards.
The tender adheres to open procedure, provides a CPV code, and has a reasonable submission deadline. No disputes are noted. The procedure appears compliant with general procurement regulations.
The title and description are clear. Key documents outlining requirements are referenced, though their full content is not immediately accessible without further steps. Evaluation criteria are not explicitly specified in the provided summary.
Basic information like title, reference, organization, and deadlines are present. Contract duration is specified. However, the estimated financial value is not disclosed, impacting overall completeness.
The tender utilizes e-procurement, which promotes fairness. However, the 'Restricted document access' flag raises concerns about full document accessibility for all potential bidders. Objective criteria are implied but not explicitly detailed.
The tender is designated as e-procurement, which is positive. However, the 'No e-submission' flag suggests potential limitations in the submission process. Financing information and contract start date are not explicitly detailed.
Key fields such as title, reference, organization, and deadlines are populated. There are no reported suspensions or disputes, and the dates appear logically sequenced.
The tender does not explicitly mention green procurement, social aspects, or innovation. It is not indicated as EU funded, suggesting a lack of specific sustainability focus.
Sign up to view complete requirements and analysis
No credit card required • Setup in 2 minutes
Our procurement experts prepare everything. Proven to work — you review, approve, and submit.
Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.
No credit card required